Neoadjuvant immune checkpoint blockade: A window of opportunity to advance cancer immunotherapy
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference99 articles.
1. Neoadjuvant checkpoint blockade for cancer immunotherapy;Topalian;Science,2020
2. Neoadjuvant PD-1 blockade in resectable lung cancer;Forde;N. Engl. J. Med.,2018
3. Event-free survival with pembrolizumab in early triple-negative breast cancer;Schmid;N. Engl. J. Med.,2022
4. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer;Forde;N. Engl. J. Med.,2022
5. Non-small cell lung cancer, version 3.2022, NCCN Clinical Practice Guidelines in Oncology;Ettinger;J. Natl. Compr. Canc. Netw.,2022
Cited by 67 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Near-infrared photoimmunotherapy as a complementary modality to in situ vaccine in a preclinical pancreatic cancer model;Biochemical and Biophysical Research Communications;2024-12
2. Novel curcumin derivatives N17 exert anti-cancer effects through the CSNK1G3/AKT axis in triple-negative breast cancer;Biochemical Pharmacology;2024-11
3. Micro/nano system-mediated local treatment in conjunction with immune checkpoint inhibitor against advanced-Stage malignant melanoma;Chemical Engineering Journal;2024-10
4. Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach;Nature Reviews Clinical Oncology;2024-09-04
5. TP53 Mutation-Mediated Immune Evasion in Cancer: Mechanisms and Therapeutic Implications;Cancers;2024-09-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3